From theory to practice – a trainee’s perspective

In Insights, Uncategorized

1 March, 2013

Although we have only scratched the surface of the complex patent world comprising “Patent Law Theory”, “Patent Application Procedure and Examination”, “Technology Licensing”,  “Litigation Practice” etc. it was boosting to come home and apply at least some of the knowledge we have gained during the trainee courses. The shifts between intensive trainee courses and home office practice seem to form an ideal bridge to quickly learn to do client work.

Since September 2012 the learning curve on intellectual property law has been steep but we have also been taught a great deal about ourselves: who we are, or rather who we are becoming. Personally, I have a longer background in research before starting as a trainee at Awapatent and I must say I am surprised to realize how sudden I have adapted to the IP culture. Hence, the conversion from one way of working to another has been surprisingly straightforward. Also, the IP theory may be difficult to comprehend and apply but now the light at the end of the tunnel is appearing. This, I ascribe the bridging between theory and practice.

Although we are all eager to become great patent attorneys I believe it is important to remember “He who would learn to fly one day must first learn to stand and walk and run and climb and dance; one cannot fly into flying” (Friedrich Nietzsche).

In other words, the process of converting theory in to practice I believe is key to become a successful qualified patent attorney.

Helle Friis Svenstrup, Awapatent Trainee

You may also be interested in:

Navigating Meta’s shifted Moderation Model: What brand owners should prepare for

Meta Platforms Inc. owns and operates some of the world’s largest social media platforms, including Facebook and Instagram, among

Read more...

Companies with IP generate at least 23.8% more revenue according to latest EU report

The report ‘The Intellectual Property Rights and Firm Performance in the European Union’ was published last month and analyses

Read more...

European Commission reports show misuse of divisionals can in itself contravene EU law

In November last year, I was interviewed about the European Commission’s €462.6 million fine against pharmaceutical giant Teva and

Read more...

Mobile Sliding Menu